Related Experiment Videos
Long-term sequelae of Palmar-Plantar erythrodysaesthesia syndrome secondary to 5-fluorouracil therapy
G K Banfield1, I D Crate, C L Griffiths
1Department of Surgical Oncology, Queen Elizabeth Military Hospital, Woolwich, London, UK.
Journal of the Royal Society of Medicine
|June 1, 1995
Abstract:
Palmar-Plantar erythrodyasesthesia syndrome has been reported as a temporary complication of 5-fluorouracil therapy consisting of a debilitating erythema and tenderness of the skin of hands and feet. The syndrome has previously been observed to respond rapidly to either temporary cessation of chemotherapy or pyridoxine with little residual disability. We report a case which was characterized by persistent morbidity necessitating prolonged discontinuation of treatment.